van der Heijden B J, Carlus C, Narcy F, Bavoux F, Delezoide A L, Gubler M C
Department of Pediatrics, Juliana Childrens Hospital, The Hague, The Netherlands.
Am J Obstet Gynecol. 1994 Sep;171(3):617-23. doi: 10.1016/0002-9378(94)90073-6.
The purpose of this study is to emphasize the high risk of renal failure and severe morphologic changes related to prolonged prenatal exposure to indomethacin.
Referred renal specimens from six anuric neonates exposed in utero to indomethacin were studied. Clinical charts were retrospectively reviewed. Indomethacin dosages varied from 150 to 400 mg daily, and the drug was given for a 2- to 11-week period, until birth.
All infants died in anuria, 4 of them after 7 to 39 days on peritoneal dialysis. In 5 infants cystic dilatations of superficial nephrons were associated with ischemic changes of the deep cortex. By immunohistochemical analysis intrarenal renin content was increased in 4 of 5 patients.
Long-term indomethacin treatment during pregnancy may lead to the development of renal failure and irreversible renal damage with cystic dilatation of developing nephrons in an exposed fetus. Prior stimulation of the renin-angiotensin system may favor this complication.
本研究旨在强调产前长期暴露于吲哚美辛与肾衰竭及严重形态学改变的高风险。
对6例宫内暴露于吲哚美辛的无尿新生儿的转诊肾脏标本进行研究。对临床病历进行回顾性分析。吲哚美辛剂量为每日150至400毫克,用药2至11周直至出生。
所有婴儿均死于无尿,其中4例在接受腹膜透析7至39天后死亡。5例婴儿浅表肾单位的囊性扩张与深部皮质的缺血性改变相关。通过免疫组化分析,5例患者中有4例肾内肾素含量增加。
孕期长期使用吲哚美辛可能导致肾衰竭的发生以及不可逆的肾损害,表现为暴露胎儿发育中的肾单位出现囊性扩张。肾素-血管紧张素系统的先前刺激可能有利于这种并发症的发生。